Capsaicin 0.075% cream
GREY after cons/spec recommendation: as per neuropathic pain guidance for patients who cannot take or tolerate oral medicines. (Decision date - May 2017, April 2023).
Capsaicin 0.025% cream
GREY: can be considered as an adjunct after NSAIDs (topical or oral) with or without paracetamol in OA. (Decision date - September 2017).